Literature DB >> 32074486

Evaluation of long-term efficacy, safety, and reasons for discontinuation of dupilumab for moderate to severe atopic dermatitis in clinical practice: A retrospective cohort study.

Christine E Jo1, Jorge R Georgakopoulos2, Matthew Ladda3, Arvin Ighani2, Asfandyar Mufti2, Aaron M Drucker4, Vincent Piguet4, Jensen Yeung5.   

Abstract

Entities:  

Year:  2020        PMID： 32074486     DOI： 10.1016/j.jaad.2020.02.029

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN： 0190-9622            Impact factor:   11.527


× No keyword cloud information.
  6 in total

1.  Real-World Effectiveness of Dupilumab in Atopic Dermatitis Patients: Analysis of an Electronic Medical Records Dataset.

Authors:  Lawrence F Eichenfield; April Armstrong; Emma Guttman-Yassky; Peter A Lio; Chi-Chang Chen; Dionne M Hines; Catherine B McGuiness; Sohini Ganguli; Dimittri Delevry; Debra Sierka; Usha G Mallya
Journal:  Dermatol Ther (Heidelb)       Date:  2022-05-11

Review 2.  Conjunctivitis in patients with atopic dermatitis treated with dupilumab.

Authors:  Sandra Ferreira; Tiago Torres
Journal:  Drugs Context       Date:  2020-05-04

3.  Efficacy and Safety of Dupilumab in Clinical Practice: One Year of Experience on 165 Adult Patients from a Tertiary Referral Centre.

Authors:  Maddalena Napolitano; Maria Ferrillo; Cataldo Patruno; Massimiliano Scalvenzi; Mirella D'Andrea; Gabriella Fabbrocini
Journal:  Dermatol Ther (Heidelb)       Date:  2021-03-13

Review 4.  A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis.

Authors:  Masahiro Kamata; Yayoi Tada
Journal:  JID Innov       Date:  2021-07-30

5.  Efficacy and Safety of Dupilumab in Chinese Patients With Atopic Dermatitis: A Real-World Study.

Authors:  Bingjing Zhou; Cong Peng; Liqiao Li; Runqiu Liu; Lei Zhu; Xiang Chen; Jie Li
Journal:  Front Med (Lausanne)       Date:  2022-03-23

Review 6.  Virus-Like Particle-Mediated Vaccination against Interleukin-13 May Harbour General Anti-Allergic Potential beyond Atopic Dermatitis.

Authors:  John Foerster; Aleksandra Molęda
Journal:  Viruses       Date:  2020-04-13       Impact factor: 5.048
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.